Bruton's tyrosine kinase inhibitors in B‐cell non‐Hodgkin's lymphomas

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|97|5|469-477

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.5, 2015-05, pp. : 469-477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Bruton's tyrosine kinase with ibrutinib in B‐cell malignancies

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 5, 2015-05 ,pp. : 455-468

John Wiley & Sons Inc

Access to resources Recommend Favorite

HCV‐associated B‐cell non‐Hodgkin lymphomas and new direct antiviral agents

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 1478-3223, Iss. 10, 2015-10 ,pp. : 2222-2227

John Wiley & Sons Inc

Access to resources Recommend Favorite

HCV3 O‐30: The efficacy of antiviral therapy in HCV associated B‐cell non‐Hodgkin lymphomas: a meta‐analysis

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 18-18

John Wiley & Sons Inc

Access to resources Recommend Favorite

HCV‐associated B‐cell non‐Hodgkin lymphomas and new direct antiviral agents

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 10, 2015-10 ,pp. : 2222-2227

John Wiley & Sons Inc

Access to resources Recommend Favorite

Isolation of Side Population Cells in B-Cell Non-Hodgkin’s Lymphomas

By  

Acta Haematologica, Vol. 129, Iss. 1, 2012-09 ,pp. : 10-17

Karger

Access to resources Recommend Favorite